Late-onset Pompe disease

Pompe disease is a rare neuromuscular disorder associated with acid maltase deficiency. The severity of clinical manifestations and age of onset correlate with the type of mutation in the GAA gene and residual activity of lysosomal α-1,4-glucosidase. The infantile form of Pompe disease is characterized by hypertrophic cardiomyopathy, generalized muscle weakness, hypotonia, hepatomegaly and death from respiratory failure within the first year of life. Late-onset Pompe disease may develop at any age and affects skeletal muscle, causing slowly progressive muscle weakness and respiratory impairment. We report a case of late-onset Pompe disease in a 30-year-old female who was diagnosed only at 8 years after the onset of disease. The initial complaints were limited to difficulty in getting up from chairs and the need to help herself by hands. Diagnosis of Pompe disease was established by low α-1,4-glucosidase activity in dried blood spot and genetic testing that showed compound heterozygous mutations in the GAA gene (c.-32-13T>G and c.2104C>T).

Authors

Publication Details

Journal
Clinical pharmacology and therapy
Published
2024-08-25
DOI
https://doi.org/10.32756/0869-5490-2024-3-63-66
Citations
4
Primary Topic
Lysosomal Storage Disorders Research
Type
article
Field-Weighted Citation Impact
0.65
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Late-onset Pompe disease

L. Alimbekova, D.R. Safina, A.T. Faskhutdinov
4 citations
Clinical pharmacology and therapy
Lysosomal Storage Disorders Research
0.65
article

Late-onset Pompe disease

L. Alimbekova, D.R. Safina, A.T. Faskhutdinov
article en
4 citations

Abstract

Pompe disease is a rare neuromuscular disorder associated with acid maltase deficiency. The severity of clinical manifestations and age of onset correlate with the type of mutation in the GAA gene and residual activity of lysosomal α-1,4-glucosidase. The infantile form of Pompe disease is characterized by hypertrophic cardiomyopathy, generalized muscle weakness, hypotonia, hepatomegaly and death from respiratory failure within the first year of life. Late-onset Pompe disease may develop at any age and affects skeletal muscle, causing slowly progressive muscle weakness and respiratory impairment. We report a case of late-onset Pompe disease in a 30-year-old female who was diagnosed only at 8 years after the onset of disease. The initial complaints were limited to difficulty in getting up from chairs and the need to help herself by hands. Diagnosis of Pompe disease was established by low α-1,4-glucosidase activity in dried blood spot and genetic testing that showed compound heterozygous mutations in the GAA gene (c.-32-13T>G and c.2104C>T).

Clinical pharmacology and therapyVol. 35(3)
Openalex Percentile: Top 29%
Lysosomal Storage Disorders Research
0.65
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.